Centre for Anxiety Disorders and Trauma
London, se5 8az, United Kingdom
NCT Number: NCT04052217
Our hypothesis is that reducing the length of the penis does not lead to loss of sexual satisfaction or emotional closeness in the female partner. This will be investigated by a single case experimental design in 12 couples.
Looking for future studies?
Notify Me18 year and older
Interventional
Not applicable
London, se5 8az, United Kingdom
The investigators will conduct a single case experimental design (SCED), in which a woman acts as her own control with a reversal design between randomly allocated phases. These include a control phase (A) and phases with various sizes of penile rings (B, C, and D).
The male participant will be asked to measure the length and girth of their erect penis using standardized instructions and flexible tape measure before the start of the experiment. This will partly determine the inner circumference of the ring provided. The male participant will be given instructions on how to use the penile rings and ensure that the female participant is blind to the size of the ring used.
There will be randomization (a) to the phase (the size of ring) and (b) the number of times of intercourse within a phase. The male partner will be blind to ratings made by the female partner. There is no carry over effect from one phase to another. The randomization of the phase means less guessing of the size of the ring, and less interaction with moderators (e.g. menstrual cycle, alcohol, holiday or life events randomly spread across phases). In a SCED, one then replicates in Case 2, Case 3 etc and a meta-analysis is conducted of all the single cases.
Randomisation will occur to either
Measures:
The investigators will use a Visual Analogue Scale (0-100) for the female participant ratings of (a) sexual pleasure and (b) how emotionally connected she felt to her partner (c) any adverse experiences.
The female participant will be asked to rate the degree of change (positive or negative) that would be significant for them e.g. a drop of rating 65 to 45) The female participant will be asked to rate satisfaction and emotional closeness as soon as possible after intercourse. The investigators will ask all participants to enter the data directly onto web based capture of data. This will be anonymized so that they will be identified by a character.
The male participant will be asked to confirm the size of the ring used and any other comments.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Penile Ring at base of penis
Time frame: Change between Control phase (A) and phase B, C, or D through study completion, on average 8 weeks
Overall Sexual Pleasure on a Visual Analogue Scale between 0-100
Time frame: Change between Control phase (A) and phase B, C, or D through study completion, on average 8 weeks
Sexual pleasure from intercourse alone on a Visual Analogue Scale between 0-100
Time frame: Change between Control phase (A) and phase B, C, or D through study completion, on average 8 weeks
Emotional Connection on a Visual Analogue Scale between 0-100
King's College London
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04512287
Connective Tissue Diseases, Genital Diseases
Miami, Florida, United States
View Trial DetailsNCT05871177
Connective Tissue Diseases, Genital Diseases
Catanzaro, Italy
View Trial DetailsNCT05480683
Connective Tissue Diseases, Genital Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT05768867
Connective Tissue Diseases, Genital Diseases
Toulouse, France
View Trial Details